Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases

Abstract

Suboptimal vitamin D (vitD) status and reduced lean body mass are highly prevalent in pediatric inflammatory bowel diseases (IBD). The study objective was to determine sarcopenia prevalence and associations with vitD status in newly diagnosed pediatric IBD. Children with Crohn’s disease (CD; n = 58) and ulcerative colitis (UC; n = 27) were included. Primary outcomes included body composition (total/regional/percent fat mass (FM), fat-free mass (FFM), skeletal muscle mass (SMM)), and vitD status (serum 25(OH)D). Sarcopenia was defined as SMM-z < –2. Additional variables measured included serum CRP, ESR, anthropometric, Pediatric Crohn’s Disease Activity Index (PCDAI), and the Pediatric Ulcerative Colitis Disease Activity index (PUCAI). Sarcopenia and suboptimal 25(OH)D levels (< 50 nmol/l) were found in 23.5% (n = 20) and 52% (n = 44) of children, respectively. Younger children (< 13 years) with CD with suboptimal 25(OH)vitD (< 50 nmol/l) had the greatest frequency of sarcopenia (57.1%) (p = 0.004). Sarcopenia was prevalent in newly diagnosed, young children with CD with vitD deficiency.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gupta N, Bostrom AG, Kirschner BS, Cohen SA, Abramson O, Ferry GD, et al. Presentation and disease course in early- compared to later-onset pediatric Crohn’s disease. Am J Gastroenterol. 2008;103:2092–2098.

    Article  Google Scholar 

  2. Thangarajah D, Hyde MJ, Konteti VK, Santhakumaran S, Frost G, Fell JM. Systematic review: Body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42:142–157.

    Article  CAS  Google Scholar 

  3. Subramaniam K, Fallon K, Ruut T, Lane D, McKay R, Shadbolt B, et al. Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn’s disease. Aliment Pharmacol Ther. 2015;41:419–428.

    Article  CAS  Google Scholar 

  4. Pappa H. Vitamin D deficiency and supplementation in patients with IBD. Gastroenterol Hepatol (N Y). 2014;10:127–129.

    Google Scholar 

  5. Stoian CA, Lyon M, Cox RG, Stephure DK, Mah JK. Vitamin D concentrations among healthy children in Calgary, Alberta. Paediatr Child Health. 2011;16:82–86.

    Article  Google Scholar 

  6. Almurdhi MM, Reeves ND, Bowling FL, Boulton AJ, Jeziorska M, Malik RA. Distal lower limb strength is reduced in subjects with impaired glucose tolerance and is related to elevated intramuscular fat level and vitamin D deficiency. Diabet Med. 2017;34:356–363.

    Article  CAS  Google Scholar 

  7. Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99:4336–4345.

    Article  CAS  Google Scholar 

  8. Rodd C, Metzger DL, Sharma A. Extending World Health Organization weight-for-age reference curves to older children. BMC Pediatr. 2014;14:32.

    Article  Google Scholar 

  9. Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, et al. Mathematical weighting of the pediatric Crohn’s disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis. 2012;18:55–62.

    Article  Google Scholar 

  10. Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423–432.

    Article  Google Scholar 

  11. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.

    Article  Google Scholar 

  12. Webber CE, Barr RD. Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents. J Cachex- Sarcopenia Muscle. 2012;3:25–29.

    Article  Google Scholar 

  13. Kim J, Shen W, Gallagher D, Jones A Jr., Wang Z, Wang J, et al. Total-body skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in children and adolescents. Am J Clin Nutr. 2006;84:1014–1020.

    Article  CAS  Google Scholar 

  14. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930.

    Article  CAS  Google Scholar 

  15. Bryant RV, Ooi S, Schultz CG, Goess C, Grafton R, Hughes J, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(9):895–906.

    Article  CAS  Google Scholar 

  16. Pojednic RM, Ceglia L, Lichtenstein AH, Dawson-Hughes B, Fielding RA. Vitamin D receptor protein is associated with interleukin-6 in human skeletal muscle. Endocrine. 2015;49:512–520.

    Article  CAS  Google Scholar 

  17. Pojednic RM, Ceglia L, Olsson K, Gustafsson T, Lichtenstein AH, Dawson-Hughes B, et al. Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells. Calcif Tissue Int. 2015;96:256–263.

    Article  CAS  Google Scholar 

  18. Proctor DN, O’Brien PC, Atkinson EJ, Nair KS. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol. 1999;277(3 Pt 1):E489–E495.

    CAS  PubMed  Google Scholar 

  19. Pannu PK, Zhao Y, Soares MJ. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr Res. 2016;36:201–213.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

Funding for this cohort was provided by Stollery Children’s Hospital foundation through the Women and Children’s Research Institute and the Canadian Children IBD Network: a joint partnership of the CH.I.L.D. Foundation and CIHR is gratefully acknowledged. KRM was funded by the Stollery Children’s Hospital Foundation/Lois Hole Hospital for Women through the Women and Children’s Health Research Institute Graduate Scholarship and the Wirtanen Graduate Scholarship (Alberta Diabetes Institute).

Author contributions

DM: study design, data analysis/interpretation, and writing/review/final approval of manuscript. MC: study design, data collection/interpretation, and writing/review manuscript. EW: study design, data collection/interpretation, and review/final approval manuscript. PM, KM, JW, CK and JW responsible for study design and data collection/review/final approval of manuscript. MC and JW: data interpretation and review/final approved manuscript. JMT: data analysis/interpretation and review/final approval manuscript. HQ: study design, data collection, data analysis/interpretation, and writing/review/final approval manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Q Huynh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mager, D.R., Carroll, M.W., Wine, E. et al. Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases. Eur J Clin Nutr 72, 623–626 (2018). https://doi.org/10.1038/s41430-018-0105-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41430-018-0105-2

This article is cited by

Search

Quick links